June 26, 2020 / 5:07 AM / 20 days ago

BRIEF-Almirall Divests Ansiolin To Neuraxpharm In Italy

June 26 (Reuters) - Almirall:

* SAID ON THURSDAY IT DIVESTED ANSIOLIN (DIAZEPAM) TO NEURAXPHARM IN ITALY

* THE AGREEMENT BETWEEN NEURAXPHARM ITALY AND ALMIRALL INCLUDES ANSIOLIN’S TWO MARKETED PRESENTATIONS: ANSIOLIN 5 MG FILM-COATED TABLETS AND ANSIOLIN 5 MG/ML ORAL DROPS SOLUTION

* ANSIOLIN (DIAZEPAM) IS INDICATED TO TREAT ANXIETY AND OTHER SOMATIC OR PSYCHIATRIC CONDITIONS ASSOCIATED TO ANXIETY SYNDROME, AND INSOMNIA

Source text: bit.ly/2YAGX4V

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below